
Keywords: ABTSâ¢; 2,2â²-azinobis(3-ethylbenzthiazoline-6-sulfonic acid free radical; Ach; acetylcholine; AchR; acetylcholine receptor; AOPP; advanced oxidation protein products; FRAP; ferric reducing antioxidant potential; GMG; generalized myasthenia gravis; MG;